Template:Herpes simplex: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(3 intermediate revisions by 3 users not shown)
Line 1: Line 1:
{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue"
{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue"
|- bgcolor="LightGrey"
!
[[Sexually transmitted disease|'''Sexually transmitted diseases Main Page''']]
|-
!
|-
|-
| colspan="1" style="text-align:center; background:DarkGray" |
| colspan="1" style="text-align:center; background:DarkGray" |
Line 13: Line 20:
|-  
|-  
!
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
Line 55: Line 63:


:[[Mollaret's meningitis|Mollaret's Meningitis]]
:[[Mollaret's meningitis|Mollaret's Meningitis]]
|-
!
|- bgcolor="Pink"
!
[[Herpes simplex pathophysiology|Pathophysiology]]
|-  
|-  
!
!
Line 78: Line 91:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Herpes simplex transmission|Transmission]]
[[Herpes simplex natural history, complications and prognosis|Natural History, Complications and Prognosis]]
|-  
|-  
!
!
|- bgcolor="CornFlowerBlue"
|- bgcolor="CornFlowerBlue"
!
!
Line 128: Line 140:
:[[Herpes simplex genitalis antiviral treatment of recurrent genital herpes|Antivirals for Recurrent Genital Herpes]]  
:[[Herpes simplex genitalis antiviral treatment of recurrent genital herpes|Antivirals for Recurrent Genital Herpes]]  


:[[Herpes simplex alternative therapies |Alternative Therapies]]
|-  
|-  
!
!
Line 134: Line 145:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Herpes simplex primary prevention|Prevention]]
[[Herpes simplex primary prevention|Primary Prevention]]
|-  
|-  
!  
!  
|- bgcolor="PaleTurquoise"
!
[[Herpes simplex complications|Complications]]
|-
!


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"

Latest revision as of 16:31, 2 March 2017